Novel Small Molecule MEK Inhibitor URML-3881 Enhances Cisplatin Sensitivity in Clear Cell Ovarian Cancer

Advanced clear cell ovarian cancer (CCOC) is a highly fatal malignancy with a scarcity of effective treatment options. CCOC is inherently chemotherapy resistance, but the exact mechanism of this resistance has yet to be established. Prosurvival signaling, such as through the MAPK cascade, is one way...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Transl Oncol
Main Authors: Rowswell-Turner, Rachael B., Rutishauser, Jennifer A., Kim, Kyu Kwang, Khazan, Negar, Sivagnanalingam, Umayal, Jones, Aaron M., Singh, Rakesh K., Moore, Richard G.
Format: Artigo
Jezik:Inglês
Izdano: Neoplasia Press 2019
Teme:
Original article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6517847/
https://ncbi.nlm.nih.gov/pubmed/31082584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2019.04.009
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki